The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The company says a turnaround will take time as the market for luxury goods cools and China muddles through economic doldrums.
Despite Humane’s lofty dreams to disrupt the smartphone status quo, critics have not been thrilled with the startup’s debut device.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Moderna says it was willing to licence the tech but now wants to be repaid by rivals for vaccine revenue generated since then.
How tech firms reconcile their desire for endless growth with bold climate goals.
A new survey finds evidence that “the drugs have a meaningful impact on consumer behavior and spending on groceries and restaurants.”
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
Experts testified in one hearing about whether the company had improved safety and compliance procedures since two major crashes.
The figure was enough to push the insurance giant to a loss in Q1, despite its revenue beating expectations.
Oakland’s move to change its airport name to include the San Francisco Bay has irritated its bigger-city neighbors.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.